Cipta Sarana Medika Tbk. vs Bank Pan Indonesia Tbk — how do they compare? Cipta Sarana Medika Tbk. trades at Rp63 (market cap 158.12B, 8.21M 24h volume), while Bank Pan Indonesia Tbk trades at Rp880 (market cap 20.62T, 5.25M 24h volume). The key difference: Bank Pan Indonesia Tbk is far larger — about 130.4× Cipta Sarana Medika Tbk.'s market cap, and Cipta Sarana Medika Tbk. is more actively traded (8.21M versus 5.25M). Which is the better fit depends on your goals.
| DKHH | PNBN | |
|---|---|---|
Market Cap | 158.12B | 20.62T |
Volume | 8.21M | 5.25M |
Lot | 82.15K | 52.51K |
Turnover | 515.2M | 4.62B |
Average Price | 62.72 | 880.1 |
Value | 515.2M | 4.62B |
Indicative Equilibrium Price | 63 | 880 |
Indicative Equilibrium Volume | 1.33K | 1.91K |
Trailing returns across standard periods
Latest headlines on both assets
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →PT Bank Pan Indonesia Tbk (the Bank) was established based on Deed No. 85 dated August 17, 1971 of notary Juliaan Nimrod Siregar gelar Mangaradja, S.H. Panin (Pan Indonesia) Bank was established by the merger of three small private banks. It was one of the first banks to be granted a foreign exchange license in 1972.
Read more on PNBN →